Ipamorelin Product Brief

1. Compound Overview

Ipamorelin is a synthetic pentapeptide belonging to the growth hormone releasing peptide (GHRP) family.
It functions as a selective ghrelin receptor (GHS-R1a) agonist, which stimulates the release of endogenous growth hormone from the pituitary gland.

Ipamorelin is commonly studied in research involving growth hormone signaling, recovery pathways, metabolic regulation, and endocrine system function.

2. Mechanism of Interest

Ipamorelin is studied for several biological mechanisms:

• Activation of the ghrelin receptor (GHS-R1a)
  • Stimulation of endogenous growth hormone release
  • Potential increase in circulating IGF-1 signaling pathways
  • Influence on metabolic and recovery-related signaling pathways
  • Interaction with endocrine regulatory systems

3. Research Areas Being Explored

• Growth hormone secretion research
  • Body composition studies
  • Recovery and regenerative pathway research
  • Metabolic signaling studies
  • Endocrine system regulation research

4. Safety and Regulatory Notes

Ipamorelin is not approved by the FDA for medical treatment and is commonly distributed as a research compound.

This document is intended for informational and research product description purposes only.